GlaxoSmithKline Pharmaceuticals Ltd.
http://www.gsk-india.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From GlaxoSmithKline Pharmaceuticals Ltd.
FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Khan Says
The agency is also poised to announce another development in its scrutiny of the drug patents listed in the FDA’s Orange Book.
Companies Reveal Hurdles In Providing Drugs Via Expanded Access Programs
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and whether physicians should report research data.
GSK Is Third Major Inhaler Maker To Cap Copays; Will Teva Follow?
It might make sense from a competitive standpoint for Teva to join the trend. That’s the way it happened in the insulin category.
GSK Is Third Major Inhaler Maker To Cap Copays; Will Teva Follow?
It might make sense from a competitive standpoint for Teva to join the trend. That’s the way it happened in the insulin category.
Company Information
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice